TScan Therapeutics TCRX
NASDAQ TCRX
$0.14 -0.01 (-6.67%)
At close: Nov 19, 2026 · 4:00 PM EST

TScan Therapeutics (TCRX) Receivables (2023)

Updated

TScan Therapeutics' Receivables came in at $31.93 million for Q2 2023.

Analysis

TScan Therapeutics (TCRX) Receivables (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00 32,417.00
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn 25.23 Bn
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn 18.99 Bn
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn 13.51 Bn
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn 12.74 Bn
6 Novartis Ag 291.91 Bn 265.14 Bn - -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn 10.35 Bn
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn 5.01 Bn
9 Gsk 193.54 Bn 176.38 Bn - 10.88 Bn
10 TScan Therapeutics 18.87 Mn -434.83 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 31.93 Mn
API Access

TScan Therapeutics Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=TCRX&period=max&api_key=YOUR_API_KEY